PainChek reports 150% year-on-year increase

PainChek, the company behind an AI-powered pain assessment tool, has reported a 150% year-on-year increase in the number of beds in UK residential care homes using the PainChek technology, with 20,000 now contracted.

The company, which started out in Australia, has conducted over 3,000,000 digital pain assessments worldwide, with 70,000 aged care beds now contracted worldwide, representing a 96% increase on the previous year.

PainChek is a regulatory cleared medical device for the assessment of pain, enabling best-practice pain management for people living with pain in any environment.

Recent adopters of the PainChek technology in the UK include the London Borough of Enfield, which will be funding PainChek across 80 cares homes consisting of 1,900 beds, Exemplar Healthcare, TLC Care, Angel Care, and Royal Star & Garter.

This year, PainChek partnered with Quality Compliance Systems (QCS) to support the 2023 review of a national pain management policy designed to help improve pain assessment and management in those who cannot reliably self-report their pain.

PainChek’s Tandeep Gill said: “Our latest figures reflect the value of the PainChek technology in UK care homes as well as worldwide. Reaching over three million pain assessments is a real milestone for us – each individual assessment brings more objectivity and consistency to evaluating and managing pain, whilst making a real difference to the lives of those suffering from pain.

“In the UK, we have been rapidly growing our network of clients and technology partners. To support rapid growth and increasing demand for PainChek, the UK team has built further capacity for customer education and training by partnering with Ark Assessment Limited. Through the partnership, pharmacists will deliver dementia education and pain management training using PainChek as part of their medication management service for aged care homes. We look forward to continuing to work closely with our partners in the UK and around the world to support best-practice pain management for more people around the globe.”